Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Balance at period start (in shares) at Dec. 31, 2019     66,320,706 13,479,000            
Balance, at period start at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) $ 1,037,141   $ (1,749) $ (75,664) $ (1,141) $ (1,518)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares)     357,974              
Exercise of stock options 3,408   $ 2   3,406          
Issuance of common stock - vesting of restricted stock units (in shares)     398,881              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 13,765       13,765          
Shares withheld to satisfy tax withholdings (in shares)       (130,164)            
Shares withheld to satisfy tax withholdings (9,199)     $ (9,199)            
Foreign currency translation losses, net of taxes (3,024)           (3,024)      
Net income (loss) (7,190)             (7,336)   146
Balance at period end (in shares) at Mar. 31, 2020     67,077,561 13,609,164            
Balance, at period end at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312   (4,773) (84,141)   (1,372)
Balance at period start (in shares) at Dec. 31, 2019     66,320,706 13,479,000            
Balance, at period start at Dec. 31, 2019 $ 867,576 (1,141) $ 331 $ (90,965) 1,037,141   (1,749) (75,664) (1,141) (1,518)
Increase (decrease) in shareholders' equity                    
Accounting Standards Update [Extensible List] env:AccountingStandardsUpdate202006Member                  
Balance at period end (in shares) at Dec. 31, 2020     67,832,706 13,739,171            
Balance, at period end at Dec. 31, 2020 $ 975,818 $ (79,842) $ 339 $ (110,466) 1,166,774 $ (108,470) (398) (79,912) $ 28,628 (519)
Increase (decrease) in shareholders' equity                    
Exercise of stock options (in shares) 27,043   27,043              
Exercise of stock options $ 522       522          
Issuance of common stock - vesting of restricted stock units (in shares)     455,349              
Issuance of common stock - vesting of restricted stock units 2   $ 2              
Stock-based compensation expense 14,013       14,013          
Shares withheld to satisfy tax withholdings (in shares)       (147,041)            
Shares withheld to satisfy tax withholdings (9,541)     $ (9,541)            
Share repurchase (in shares)       (24,227)            
Share repurchase (1,672)     $ (1,672)            
Foreign currency translation losses, net of taxes (624)           (624)      
Other 118                 118
Net income (loss) 14,935             14,946   (11)
Balance at period end (in shares) at Mar. 31, 2021     68,315,098 13,910,439            
Balance, at period end at Mar. 31, 2021 $ 913,729   $ 341 $ (121,679) $ 1,072,839   $ (1,022) $ (36,338)   $ (412)